162 related articles for article (PubMed ID: 37653618)
1. Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for Construction of Drug Delivery Platforms Via Optimized Biomimetics.
Xiao Y; Xu RH; Dai Y
Small; 2024 Jan; 20(1):e2304824. PubMed ID: 37653618
[TBL] [Abstract][Full Text] [Related]
2. Pretreating Mesenchymal Stem Cells with Cancer Conditioned-Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells.
Lupu-Haber Y; Bronshtein T; Shalom-Luxenburg H; D'Atri D; Oieni J; Kaneti L; Shagan A; Hamias S; Amram L; Kaneti G; Cohen Anavy N; Machluf M
Adv Healthc Mater; 2019 May; 8(10):e1801589. PubMed ID: 30963725
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
Shin MJ; Park JY; Lee DH; Khang D
Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
[TBL] [Abstract][Full Text] [Related]
4. [Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy].
Wang X; Ouyang X; Sun X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):525-533. PubMed ID: 30693696
[TBL] [Abstract][Full Text] [Related]
5. Reconstructed stem cell nanoghosts: a natural tumor targeting platform.
Toledano Furman NE; Lupu-Haber Y; Bronshtein T; Kaneti L; Letko N; Weinstein E; Baruch L; Machluf M
Nano Lett; 2013 Jul; 13(7):3248-55. PubMed ID: 23786263
[TBL] [Abstract][Full Text] [Related]
6. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy.
Fan L; Wei A; Gao Z; Mu X
Biomed Pharmacother; 2023 May; 161():114451. PubMed ID: 36870279
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.
Muslimov AR; Timin AS; Bichaykina VR; Peltek OO; Karpov TE; Dubavik A; Nominé A; Ghanbaja J; Sukhorukov GB; Zyuzin MV
Biomater Sci; 2020 Feb; 8(4):1137-1147. PubMed ID: 31584052
[TBL] [Abstract][Full Text] [Related]
8. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
Mohr A; Zwacka R
Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
[TBL] [Abstract][Full Text] [Related]
9. Cell Membranes from Tumor-Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy.
Song Y; Shou X; Sheng B; Mei J; Shi K; Shang L; Zhu X
Adv Healthc Mater; 2023 Jul; 12(17):e2202904. PubMed ID: 36815538
[TBL] [Abstract][Full Text] [Related]
10. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles.
Joshi S; Allabun S; Ojo S; Alqahtani MS; Shukla PK; Abbas M; Wechtaisong C; Almohiy HM
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903399
[TBL] [Abstract][Full Text] [Related]
12. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
13. Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
Timaner M; Letko-Khait N; Kotsofruk R; Benguigui M; Beyar-Katz O; Rachman-Tzemah C; Raviv Z; Bronshtein T; Machluf M; Shaked Y
Cancer Res; 2018 Mar; 78(5):1253-1265. PubMed ID: 29301792
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer.
Weng Z; Zhang B; Wu C; Yu F; Han B; Li B; Li L
J Hematol Oncol; 2021 Sep; 14(1):136. PubMed ID: 34479611
[TBL] [Abstract][Full Text] [Related]
15. Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer.
Yao S; Li X; Liu J; Sun Y; Wang Z; Jiang Y
Drug Deliv; 2017 Nov; 24(1):1372-1383. PubMed ID: 28920712
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.
Wu HH; Zhou Y; Tabata Y; Gao JQ
J Control Release; 2019 Jan; 294():102-113. PubMed ID: 30553849
[TBL] [Abstract][Full Text] [Related]
17. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering.
Xu X; Xu L; Xia J; Wen C; Liang Y; Zhang Y
Acta Biomater; 2023 Sep; 168():372-387. PubMed ID: 37481194
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
Huang X; Guo H; Wang L; Zhang Z; Zhang W
Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic Culture Strategies for the Clinical Expansion of Mesenchymal Stromal Cells.
Wong KU; Zhang A; Akhavan B; Bilek MM; Yeo GC
ACS Biomater Sci Eng; 2023 Jul; 9(7):3742-3759. PubMed ID: 33599471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]